News and Alert
For all Tower Hamlets Extended Hours Hubs staff
Welcome to Tower Hamlets Extended Hours Hubs update and information page.
Here you will find all the recent clinical and non-clinical updates and information's.
Updated: 13th April 2018
Prescription Forms & Fraud
https://cfa.nhs.uk/resources/downloads/guidance/Management%20and%20control%20of%20prescription%20forms_v1.0%20March%202018.pdf
New HPA guidance re HPV vaccination
https://www.gov.uk/government/publications/hpv-vaccination-for-msm-guidance-for-health-professionals
Lyme Disease – new NICE guidance
https://www.nice.org.uk/guidance/ng95
Adults with LD – New NICE guidance
https://www.nice.org.uk/guidance/ng96
Updated: 12th April 2018
NICE Guidance Emergency and Acute Care for over 16 year olds
https://www.nice.org.uk/guidance/ng94
Marvelon SPC has been updated with information on hepatitis C virus (HCV) and risk of elevated ALT due to HCV combination regimens co-administered with ethinylestradiol products. Concomitant use with ombitasvir/paritaprevir/ritonavir and dasabuvir is contraindicated.
https://www.medicines.org.uk/emc/product/1359/smpc
Fentanyl SPC now adds detail that fentanyl is metabolised by CYP3A4 and that caution should be used when prescribing for patients taking CYP3A4 inducers (e.g. phenytoin) and inhibitors (e.g. itraconazole).
https://www.medicines.org.uk/emc/product/6432/smpc
NICE guidance on treatment of Otitis Media
https://www.nice.org.uk/guidance/ng91
Increase in scarlet fever notifications - information from Public Health England
http://www.gpcaregroup.org/uploads/9/4/3/5/94359953/increase_in_scarlet_fever_cases_in_london.pdf
Updated: 22nd March 2018
Guidance on Prescribing Responsibilities between Primary& Secondary Care
https://www.england.nhs.uk/wp-content/uploads/2018/03/responsibility-prescribing-between-primary-secondary-care-v2.pdf
Prednisolone in people with systemic sclerosis
https://www.medicines.org.uk/emc/product/7650/smpc
Changes to Augmentin SPC to include systemic eosinophilia and systemic symptoms as potential adverse reaction
https://www.medicines.org.uk/emc/product/280/smpc
Ulipristol and monitoring LFTs
https://www.gov.uk/drug-safety-update/esmya-ulipristal-acetate-for-uterine-fibroids-do-not-initiate-or-re-start-treatment-monitor-liver-function-in-current-and-recent-users
Addition of intestinal obstruction to adverse reactions for dulaglutide
https://www.medicines.org.uk/emc/product/8246/smpc
New Guidance on the assessment and management of heavy menstrual bleeding
https://www.nice.org.uk/guidance/ng88
Updated: 28th Feb 2018
Simvastatin
https://www.medicines.org.uk/emc/product/7787/smpc
Bupronorphine Patches
https://www.medicines.org.uk/emc/product/7372/smpc
Clarithromycin in patients with heart disease
https://www.fda.gov/Drugs/DrugSafety/ucm597289.htm
Concomitant use of ACE inhibitor with sacubitril/valsartan contraindicated
https://www.medicines.org.uk/emc/product/2760/smpc
Updated: 15th Feb 2018
Norethisterone 5mg
https://www.medicines.org.uk/emc/product/1717/smpc
Norethisterone 350mcg
https://www.medicines.org.uk/emc/product/1146/smpc
SIGN Migraine guideline
http://www.sign.ac.uk/assets/sign155.pdf
Updated: 13th Feb 2018
For Uterine Fibroids: Monitor Liver Function In Current And Recent Users; Do Not Initiate Treatment In New Users Or Those Between Treatment Courses
https://www.cas.dh.gov.uk/ViewAndAcknowledgment/viewAlert.aspx?AlertID=102706
We hope you will enjoy working for the Care Group and provide us with feedback whenever you feel there are services or staff experiences we could improve on. You can email us your feedback on [email protected]
|
Partner in
|
©Tower Hamlets GP Care Group CIC 2017. All rights reserved.